TMS is a Cost Effective Alternative to Antidepressant Medication in Pharmacoresistant Major Depression: A Propensity-Score Matched Health Economic Analysis
Main Authors: | Mark A. Demitrack, MD, David G. Brock, MD, Ziad Nahas, MD, Angela Waltman, Annie N. Simpson, PhD, Kit N. Simpson, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-03-01
|
Series: | Brain Stimulation |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X15005045 |
Similar Items
-
Efficacy Comparison of NeuroStar TMS and Antidepressant Medications in the Treatment of Pharmacoresistant Major Depression
by: Mark A. Demitrack, et al.
Published: (2014-09-01) -
Potential Impact of on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
by: Sung Hwan Lee MD, PhD, et al.
Published: (2019-02-01) -
Comparison of Outcomes Between McKeown and Sweet Esophagectomy in the Elderly Patients for Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
by: Dongni Chen PhD, et al.
Published: (2020-02-01) -
Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis
by: Slavica Janeva, MD, et al.
Published: (2020-12-01) -
Early Intubation and Increased Coronavirus Disease 2019 Mortality: A Propensity Score–Matched Retrospective Cohort Study
by: Austin J. Parish, MD, MS, et al.
Published: (2021-06-01)